Register Now
Youtube Linkedin Facebook

Warning: Undefined array key "file" in /var/www/vhosts/dxpx-conference.com/httpdocs/wp-includes/media.php on line 1768
dxpx general logo white text

DxPx U.S. 2024 Media Partners

Our Media Partners

Founded in 1997 and headquartered in New York, GenomeWeb is an independent online news organization that serves the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and molecular diagnostics. GenomeWeb covers the scientific and economic ecosystem spurred by the advent of high-throughput genome sequencing. We operate the largest online newsroom focused on advanced molecular research tools to provide readers with exclusive news and in-depth analysis of this rapidly evolving market. GenomeWeb users can be found in major scientific organizations around the world, including biopharmaceutical companies, research universities, biomedical institutes, clinical labs, and government laboratories.

Precision Medicine Online launched in 2023 as an expansion of Precision Oncology News, which was created in 2019 to cover the application of genomic sequencing and other biomarker-driven approaches to guide cancer treatment. Our dedicated online newsroom tracks the industry players and healthcare systems driving the adoption of precision medicine in oncology, rare disease, cardiovascular disease, autoimmune disease, pharmacogenomics, and more; regulatory, policy, legal, and ethical issues affecting the field; and the challenges of implementing precision medicine as the standard of care.

360Dx is published by GenomeWeb, an independent online news organization based in New York. 360Dx, launched in 2016, covers emerging economic and technological trends in the clinical diagnostic market. Our dedicated online newsroom tracks the biggest players in the diagnostics market and reports on regulatory, reimbursement, and policy issues that impact the commercial operations of clinical labs.

Date & Location:

July 30 – August 1, 2024 in Chicago, IL at the ADLM 2024 Clinical Lab Expo

McCormick Place Convention Center
2301 South King Dr., Chicago, IL 60616

Be in the spotlight

Pitch your business

In 2024, for the first time we plan to host the finals of 42plus1 – the world‘s only pitch competition just for startups focusing on diagnostics, digital health, precision medicine & life science tools as part of our U.S. conference at ADLM 2024.

Each application is reviewed by at least a dozen VCs and industry executives and their feedback is shared after the pitch award.  

Enter your startup today and compete for up to $2,000,000 in funding! Learn more and register at 42plus1.com

Own the spotlight with a booth

A booth at DxPx is your personal pre-built & branded hub in the heart of ADLM 2024. You are able to showcase your innovation to all DxPx and ADLM 2024 participants and you will be promoted as an ADLM 2024 exhibitor! One FREE Startup/Growth Company ticket is included with booth purchase. Visit the DxPx Ticket Shop to learn more.

Don't miss our investor conferences & early-stage investing events:

dxpx us adlm logos
DxPx US

DxPx Industry & Investor Conference US:
4 Days In-Person

July 29 - Aug. 1, 2024
Chicago, IL
In the ADLM

Stay up to date and sign up for our latest news:

Next: DxPx U.S. 2025
  • 3 Days In-Person
  • July 29 - 31, 2025
  • McCormick Place
    Convention Center
    Chicago, Illinois, USA
Next: DxPx EU 2026
  • 2 Days In-Person
  • Reception: February 5, 2026
    Partnering Day & 42PLUS1:
    February 6, 2026
  • Munich, Germany
Download Brochure
DxPx media
Useful links

© Copyright DxPx 2025. All Rights Reserved.

Youtube Linkedin Facebook

Oliver Dick

Oliver brings 30+ years of experience in the life sciences industry, has worked in pharma, biotechnology and in vitro diagnostics. His areas of expertise fall under Supply Chain Management, Planning, Production, QC, QA, Engineering, Technology Transfer and Process Improvement. Amongst his vast experience, Oliver held functions such as Vice President of Global Manufacturing at QIAGEN, Chief Operating Officer at Miltenyi Biotec or Chief Operating Office of Resolve Biosciences. He demonstrated exceptional leadership and expertise in driving manufacturing excellence on a global scale.

Oliver has a proven ability to streamline processes, optimize production efficiency, and foster a culture of innovation. He was responsible for strategy development, scaling, cost control and quality and was part of multiple M&A projects and transfer of many new products from acquisition or own development. Today Oliver offers his expertise mainly through his own Consultancy Service Company ODICON.

Experience

Christoph Brandenberger

Christoph Brandenberger is a Managing Director at BGL and a leader in the firm’s Diagnostics, Research Tools & Medical Devices investment banking group. He has more than 20 years of experience in all aspects of mergers and acquisitions, commercialization and partnering agreements, and private placements.

A native of Austria and fluent in German, Christoph’s investment banking experience, coupled with his background in international business, has made him a sought-after advisor in both the domestic and international healthcare markets.

Prior to joining BGL, Christoph served as managing director for Healthios Capital Markets, LLC. Christoph started his career as a financial analyst for Bank of America Securities.

Experience

John Riddle

John Riddle is a Managing Director and member of the BGL Executive Committee. He has more than 30 years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic assignments.

John leads BGL’s advisory activities in the Healthcare & Life Sciences investment banking group, which comprises both corporate investment banking and real estate capital markets capabilities. Together with his team, John maintains an ongoing coverage effort with broad activity across several sectors, including health facilities, physician services, and ancillary providers; diagnostics and research tools; medical device and products; and select healthcare technology verticals, including payor services, data analytics, and clinical automation.

Experience

Dr. Mirko Stange

Born in Bremen, Germany in 1974, Dr. Mirko Stange is a diagnostics and life sciences expert with a proven track record in turning around and commercializing innovations. He possesses extensive executive management experience, having led diagnostics and biotech startups, as well as developing and conducting consulting products. Following the completion of his Ph.D. in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill, Dr. Stange began his career in 2004 at the strategy consultancy McKinsey. Subsequently, he worked with the turnaround-specialized advisory firm Droege & Comp., primarily serving clients from the pharma and chemistry industry in Germany and Switzerland.

In 2008, he founded an independent Life Sciences consultancy in Germany where, to date, he leads and directs a team of international experts. This team identifies and funds SMEs with high potential for national and international leverage. In addition to his over ten years of experience in independent corporate finance and management consulting, Mirko Stange provides interim management services to selected clients. To date, three companies co-founded and managed/advised by Dr. Stange have been successfully exited. Leveraging his scientific background, he is also a named inventor on several granted and pending patents.

Experience

FName LName

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Experience